Pharmacom Labs PHARMA Bold 300 Lab Test Results

Pharmacom Labs PHARMA Bold 300 (Equipoise)

Introduction

Pharmacom Labs PHARMA Bold 300 is marketed as containing 300 mg/ml of boldenone undecylenate and is presented in a 10-milliliter multidose vial. To verify its label claims and ensure product transparency, AnabolicLab acquired samples of this product and submitted them for independent laboratory analysis.

The analysis, conducted by SIMEC AG, revealed that the product contained 314.4 mg/ml of boldenone undecylenate, which is 104.8% of the declared dosage. This indicates a slightly overdosed product. The product was confirmed to be free from microbiological, yeast, or mold contamination, ensuring sterility. The analysis and sample submission were funded by AnabolicLab as part of its mission to promote transparency and harm reduction in the anabolic steroid market.


Product Overview

  • Manufacturer: Pharmacom Labs
  • Product Name: PHARMA Bold 300
  • Active Ingredient: Boldenone Undecylenate
  • Code Number: 604331
  • Expiration Date: July 2017
  • Quality Code: a8wm70jc2d (verified on pharmacomlabs.com/code)
  • Delivery Method: Injectable (10 mL multidose vial, 300 mg/mL as per label claim)
  • Specification: 300 mg/mL boldenone undecylenate

Sample Acquisition and Testing

  • Date Purchased: Between August 1, 2016, and September 15, 2016
  • Source: European-based internet supplier
  • Product Submitted By: AnabolicLab
  • Analysis Paid For By: AnabolicLab
  • Analysis Performed By: SIMEC AG
  • Date Received by Lab: September 29, 2016
  • Date Report Completed: October 31, 2016

Testing Results

  1. Quantitative Dosage Testing (HPLC-UV):
    • Claimed Dosage: 300 mg/mL
    • Measured Dosage: 314.4 mg/mL boldenone undecylenate
    • Accuracy: 104.8% (slightly above label claim)
  2. Microbiological Testing (TAMC and TYMC):
    • Result: No microbiological contamination detected

Summary

Pharmacom Labs PHARMA Bold 300 was determined to contain 314.4 mg/ml boldenone undecylenate, slightly exceeding the declared 300 mg/ml, indicating 104.8% of the label claim. The product demonstrated good consistency and sterility. By funding the analysis and submitting the samples, AnabolicLab emphasizes the importance of independent testing to ensure transparency and harm reduction in the anabolic steroid market.


Disclaimer: The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Pharmacom Labs PHARMA Bold 300 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 (boldenone undecylenate) Pharmacom Labs PHARMA Bold 300 (Equipoise) Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 (Equipoise) Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 Pharmacom Labs PHARMA Bold 300 quality code verrified

Pharmacom Labs PHARMA Bold 300 Dosage Quantification Lab Results [PDF]
Pharmacom Labs PHARMA Bold 300 Dosage Quantification Lab Results [PDF]
How many milligrams of boldenone undecylenate are in each milliliter of Pharmacom Labs PHARMA Bold 300? Is the product free of microbiological contamination? HPLC-UV, TAMC, TYMC (October 31, 2016) …
Size1.52 MB
Downloaded899 times
Last UpdatedNovember 15, 2016
Download